Anuradha Lala-Trindade (Anu Lala) MD
@dranulala.bsky.social
Heart Function cardiologist 🫀 Co-Editor-in-Chief, JCF. Program Director AHFTC Fellowship, Mount Sinai Fuster Heart Hospital. Training in #integrativemedicine #mindfulness #spirituality to promote health & well-being. 🙏🏽❤️🧘🏽♀️
The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology onlinejcf.com/article/S107... @drmarthagulati.bsky.social @dranulala.bsky.social @jcardfail.bsky.social
Outcomes Among Pregnant Women with Hypertrophic Cardiomyopathy: Racial & Ethnic Differences in the US #CardioObstetrics #CardioSky onlinejcf.com/article/S107... @jcardfail.bsky.social @dranulala.bsky.social @abraguo.bsky.social @vietheartpa.bsky.social @anastasiasmihaili.bsky.social
Outcomes Among Pregnant Women with Hypertrophic Cardiomyopathy: Racial and Ethnic Differences in the United States.
Hypertrophic cardiomyopathy (HCM) affects 1 out of 500 people and is the most common genetic heart disease 1. Pregnancy outcomes among women with HCM are not well described primarily due to small samp...
onlinejcf.com
People. Experience. Community. Since 2020, it's been how we measure impact at JCF. When numbers reflect our mission, it's even sweeter 💜 🎉 JCF’s 2024 Impact Factor is ⬆️ 8.2 (from 6.7 in 2023) 🫀 Watch how we’re making a difference ⬇️
Dr. Rose Tompkins presents on CVD risk in Pregnancy #WIHD25 #cardioobstetrics 🤰prepregnancy risk stratification essential 🤰🏼CARPREG Score is a tool to use in CHD (WHO & ZAHARA can be used) 🤰🏽contraception&communication 🔑 about pregnancy risk 🤰🏾team approach #cardiosky @womensheart.bsky.social
🚨Call for Papers for a Hemodynamics Focus Issue Guest Editors Drs. Daniel Burkhoff, Mark Belkin & Susanna Mak will oversee this issue, publishing Fall 2025. 📝Paper Categories & Topic Areas: bit.ly/4jwLP1H 🗓️Submit Your Paper by June 30, 2025: bit.ly/3R8TQhb
Tremendously excited to work w/JCFINT EiC Jason Katz & ⭐️ Editorial Board (more announcements this week!) as we expand @jcardfail.bsky.social #JCFFamily & provide new 🏠 for your #HeartFunction science! #CardioSky @hfsa.bsky.social @robmentz.bsky.social @dranulala.bsky.social
JCF Intersections@jcfint.bsky.social · last yr.👋 JCF-I's Deputy Editor Dr. Nosheen Reza. She is an adv HF + genetic cardiologist at U of Pennsylvania w/ NIH & @accintouch.bsky.social -funded research focused on genetic cardiomyopathies. Among her editorial positions, she served as @hfsa.bsky.social @jcardfail.bsky.social Assoc Editor since 2022
Uplifting AM boost at #ACC25 w/ Becoming a Leader in CV Med Panel My takeaways 🫀know your "why" when saying yes 🫀take the ego boost out of opportunities 🫀your definition of success >society's definition @accintouch.bsky.social #cardiosky @dranulala.bsky.social @leahkosyakovsky.bsky.social
🎧 New #HFA CardioTalk Episode! @escardio.bsky.social @novitham.bsky.social ‼️ Heart failure doesn’t affect everyone equally 🔍 Hidden disparities in heart failure care 🚀 Actionable steps to drive equity in prevention & treatment with @dranulala.bsky.social ➡️ Listen now: esc365.escardio.org/event/1983
ESC 365 - the cardiology knowledge hub
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
esc365.escardio.org
Love this woman. #KatieBerlacher has taught us so much. Grateful & inspired. Fabulous opening to #ACC2025 @accintouch.bsky.social #CardioSky @jennaskowronski.bsky.social @noshreza.bsky.social
Just in time for #ACC25 & #nationaltriglyceridesday from the @aspcardio.bsky.social & @nationallipid.bsky.social Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus from the ASPC and NLA #CVPrev #cardiosky 📎 www.sciencedirect.com/science/arti...
Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology
Extreme hypertriglyceridemia, defined as triglyceride (TG) levels ≥1000 mg/dL, is almost always indicative of chylomicronemia. The current diagnostic …
sciencedirect.com
Excited to co-publish this comprehensive 📝 on underpinnings of HFpEF in 🚺 in @jcardfail.bsky.social & @ajpcardio.bsky.social 🤝 btwn #FunctionNotFailure & 🫀#Prevention is key! Unique 🧠 input from menopause guru 🩺 🙏🏽❤️ @drmarthagulati.bsky.social @cardioob.bsky.social onlinejcf.com/article/S1071-…
Dr Martha Gulati@drmarthagulati.bsky.social · last yr.Our joint publication with @jcardfail.bsky.social & @ajpcardio.bsky.social is out! Underpinnings of #HeartFailure With Preserved Ejection Fraction in Women - From Prevention to Improving Function #HFpEF #CVPrev #CardioTwitter #womenshearthealth #heartmonth 📎 onlinejcf.com/article/S107...
Excited to co-publish this comprehensive 📝 on underpinnings of HFpEF in 🚺 in @jcardfail.bsky.social & @ajpcardio.bsky.social 🤝 btwn #FunctionNotFailure & 🫀#Prevention is key! Unique 🧠 input from menopause guru 🩺 🙏🏽❤️ @drmarthagulati.bsky.social @cardioob.bsky.social onlinejcf.com/article/S1071-…
Dr Martha Gulati@drmarthagulati.bsky.social · last yr.Our joint publication with @jcardfail.bsky.social & @ajpcardio.bsky.social is out! Underpinnings of #HeartFailure With Preserved Ejection Fraction in Women - From Prevention to Improving Function #HFpEF #CVPrev #CardioTwitter #womenshearthealth #heartmonth 📎 onlinejcf.com/article/S107...
Our joint publication with @jcardfail.bsky.social & @ajpcardio.bsky.social is out! Underpinnings of #HeartFailure With Preserved Ejection Fraction in Women - From Prevention to Improving Function #HFpEF #CVPrev #CardioTwitter #womenshearthealth #heartmonth 📎 onlinejcf.com/article/S107...
Going to #THT2025? Looking forward to the latest science in heart failure therapeutics and reconnecting with colleagues! I’m still looking to connect w my Medtwitter folks here on Bluesky. @dranulala.bsky.social
Reassessing need for primary prevention ICD in contemporary patients with HF #CardioSky #MedSky onlinejcf.com/article/S107... @jcardfail.bsky.social @robmentz.bsky.social @dranulala.bsky.social @sjgreene-md.bsky.social @ktamirisamd.bsky.social @vietheartpa.bsky.social
Join Us Feb 26th 6:30pm EST for "Lifting the Curtain: Learning Time Management Tips from Successful Cardiologists" 💠Learn tips on balancing career & parenting 💠Learn how AI & tech can help you 💠Learn how to prioritize competing demands #AHAWIC
Very nice viewpoint from @dranulala.bsky.social who walks the walk www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social #JACCAdv
Dearest @dranulala.bsky.social Wishing you the happiest birthday. You bring so much love and light into this world and I am so lucky to have to feel that because I am in your universe. Wishing you the best day. We love you. Cheers 🥂 to you! 🎂🎈🎉 @robmentz.bsky.social @quentinyoumans.bsky.social
Happiest of birthdays to the one and only @dranulala.bsky.social! This is one of my all time fav photos! It has been one of the greatest joys of my professional career to be on the @jcardfail.bsky.social journey with you!! Your light shines love on all those around you @drmarthagulati.bsky.social
Antithrombotic Strategies With Left Ventricular Assist Devices #SOTA #JCF #CardioSky @jcardfail.bsky.social @robmentz.bsky.social @dranulala.bsky.social onlinejcf.com/article/S107...
Novel ExCiTe approach aimed at improving trainee recruitment into AHFTC. Great work Edan Zitelny, Rachna Kataria & team @noshreza.bsky.social @cardionerds.bsky.social @robmentz.bsky.social @dranulala.bsky.social @jcardfail.bsky.social @shelleyzieroth.bsky.social onlinejcf.com/article/S107...
👋🫀 Hello #CardioSky community! We’re the Society for Cardiovascular Angiography & Interventions and the home of #InterventionalCardiology! Follow us for updates on the latest research, educational resources, and events (including our upcoming #SCAI2025 meeting)!
With a fully remote team of just 20 employees, Bluesky has surpassed 20 million users in its first year since opening to the public and is stealing thunder from rivals hundreds of times its size. At a time when conventional wisdom among bosses is that workers must be in-person to be productive.
Excited to share our latest in Nature Cardiovascular Research led by ⭐️ @artschuermans.bsky.social ! #CardioSky #MedSky Open access paper here: www.nature.com/articles/s44... Great thread from Art below 👇
Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction - Nature Cardiovascular Research
Schuermans et al. identify a causal relationship between the circulating proteins spondin-1 and atrial fibrillation and SPINT1 and coronary artery disease and show that adding proteomic data improves ...
nature.com
Art Schuermans@artschuermans.bsky.social · 2y agoWhat does the circulating proteome teach us about common heart diseases? Thrilled to share our analysis identifying new biomarkers, drug targets, and prediction models for these conditions. Mentored (supremely) by @mchonig.bsky.social and @pnatarajanmd.bsky.social nature.com/articles/s44... (1/x)
Go figure🤷🏽♀️ May we use these platforms to inform, educate, connect & uplift - for the common good/evolution 🙏🏽❤️🫀🧘🏽♀️ @drmarthagulati.bsky.social @cardioobdoc.bsky.social @robmentz.bsky.social @jimjanuzzi.bsky.social @glaucomflecken.bsky.social #CardioSky #MedSky
🦋 vs Twitter/X 🦋 You need to REPOST. Unlike Twitter, liking a post does NOT promote or increase visibility of that post. 🦋 Use #CardioSky #MedSky & other hashtags when posting. Bluesky has feeds (e.g. #CardioSky) that work based on hashtags. #CardioSky Feed: bsky.app/profile/did:...
bsky.app
Parham Eshtehardi MD@cardioobdoc.bsky.social · 2y ago#AHA24 version of #Skytorial for #CardioSky newcomers 1/2 🦋 Unlike Twitter, liking a post does NOT promote or increase visibility of that post. You need to REPOST. 🦋 Follow #CardioSky community by using this starter pack go.bsky.app/562nfhZ #MedSky @ahascience.bsky.social
Check out "Antithrombotic Strategies With LVADs" An absolutely 🔥 State-of-the-Art Review out now @jcardfail.bsky.social @dranulala.bsky.social @drmarthagulati.bsky.social #CardioSky onlinejcf.com/article/S107...
Nice coverage of SUMMIT @tctmd.bsky.social Well-executed trial; large benefit w tirzepatide in HFpEF + obesity Note sample size modest (731) & modest number of events (92) @dranulala.bsky.social @jgrapsa.bsky.social @drmarthagulati.bsky.social #cardiosky www.tctmd.com/news/summit-...
SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity
HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions remain.
tctmd.com
